383 related articles for article (PubMed ID: 35730908)
21. LINC00662 Promotes Oral Squamous Cell Carcinoma Cell Growth and Metastasis through miR-144-3p/EZH2 Axis.
Yao Y; Liu Y; Jin F; Meng Z
Yonsei Med J; 2021 Jul; 62(7):640-649. PubMed ID: 34164962
[TBL] [Abstract][Full Text] [Related]
22. Long non‑coding RNA AFAP1‑AS1 facilitates the growth and invasiveness of oral squamous cell carcinoma by regulating the miR‑145/HOXA1 axis.
Li M; Yu D; Li Z; Zhao C; Su C; Ning J
Oncol Rep; 2021 Mar; 45(3):1094-1104. PubMed ID: 33650645
[TBL] [Abstract][Full Text] [Related]
23. Long Noncoding RNA TFAP2A-AS1 Suppressed Hepatitis B Virus Replication by Modulating miR-933/HDAC11.
Cheng Y; Shi W; Cui X; Sun L; Nan Y; Yao H; Fan J; Zhu L; Yu L
Dis Markers; 2022; 2022():7733390. PubMed ID: 35478990
[TBL] [Abstract][Full Text] [Related]
24. SNHG17/miR-384/ELF1 axis promotes cell growth by transcriptional regulation of CTNNB1 to activate Wnt/β-catenin pathway in oral squamous cell carcinoma.
Qiao C; Qiao T; Yang S; Liu L; Zheng M
Cancer Gene Ther; 2022 Jan; 29(1):122-132. PubMed ID: 33531646
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA TUG1 regulates the development of oral squamous cell carcinoma through sponging miR-524-5p to mediate DLX1 expression as a competitive endogenous RNA.
Liu S; Liu LH; Hu WW; Wang M
J Cell Physiol; 2019 Nov; 234(11):20206-20216. PubMed ID: 30980391
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
27. LncRNA DLEU1 facilitates the progression of oral squamous cell carcinoma by miR-126-5p/GAB1 axis.
Sun KD; Ni YJ; Qin H; Xu QF
Kaohsiung J Med Sci; 2022 Oct; 38(10):950-959. PubMed ID: 36039933
[TBL] [Abstract][Full Text] [Related]
28. The oncogenic role of TFAP2A in bladder urothelial carcinoma via a novel long noncoding RNA TPRG1-AS1/DNMT3A/CRTAC1 axis.
He J; Dong C; Zhang H; Jiang Y; Liu T; Man X
Cell Signal; 2023 Feb; 102():110527. PubMed ID: 36410635
[TBL] [Abstract][Full Text] [Related]
29. Exosome-mediated long noncoding RNA (lncRNA) PART1 suppresses malignant progression of oral squamous cell carcinoma via miR-17-5p/SOCS6 axis.
Du Y; Shuai Y; Wang H; Li H; Li Y
Turk J Med Sci; 2023 Jun; 53(3):630-639. PubMed ID: 37476905
[TBL] [Abstract][Full Text] [Related]
30. FUT8-AS1/miR-944/Fused in Sarcoma/Transcription Factor 4 Feedback Loop Participates in the Development of Oral Squamous Cell Carcinoma through Activation of Wnt/β-Catenin Signaling Pathway.
Geng Z; Huang Y; Wu S; Zhu D; Li W
Am J Pathol; 2023 Feb; 193(2):233-245. PubMed ID: 36697118
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of lncRNA HOXA-AS2 promotes the progression of oral squamous cell carcinoma by mediating SNX5 expression.
Li Z
BMC Mol Cell Biol; 2022 Dec; 23(1):59. PubMed ID: 36528556
[TBL] [Abstract][Full Text] [Related]
32. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
[TBL] [Abstract][Full Text] [Related]
33. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300
[TBL] [Abstract][Full Text] [Related]
34. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
35. lncRNA NR2F2-AS1 inhibits the methylation of miR-494 to regulate oral squamous cell carcinoma cell proliferation.
Liang Y; Wu X; Lee J; Yu D; Su J; Guo M; Meng N; Qin J; Fan X
Arch Oral Biol; 2022 Feb; 134():105316. PubMed ID: 34896865
[TBL] [Abstract][Full Text] [Related]
36. CircLDLRAD3 inhibits Oral squamous cell carcinoma progression by regulating miR-558/Smad4/TGF-β.
Zhang X; Guo GY; Liu RY; Wu T; Wang ZH; Zhang ZT
J Cell Mol Med; 2023 Nov; 27(21):3271-3285. PubMed ID: 37563869
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic circDHTKD1 promotes tumor growth and metastasis of oral squamous cell carcinoma in vitro and in vivo via upregulating miR-326-mediated GAB1.
Wu Z; He X; Chen S
Braz J Med Biol Res; 2021; 54(10):e10837. PubMed ID: 34287578
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/β-catenin signaling pathway.
Wang Z; Guan W; Ma Y; Zhou X; Song G; Wei J; Wang C
BMC Cancer; 2023 Jul; 23(1):668. PubMed ID: 37460940
[TBL] [Abstract][Full Text] [Related]
39. FOXN3 Expression Regulated by miR-299-5p Inhibiting the Proliferation, Migration and Invasion of Oral Squamous Cell Carcinoma Cells.
Maimaitiming K; Yilihamu A; Keyimu K; Keranmu R; Li J; Xu H; Wufuer D
Protein Pept Lett; 2022; 29(9):788-795. PubMed ID: 35975858
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of miR-519d-3p Inhibits Viability, Proliferation, and G1/S Cell Cycle Transition of Oral Squamous Cell Carcinoma Cells Through Targeting CCND1.
Zhang W; Hong W
Cancer Biother Radiopharm; 2024 Mar; 39(2):153-163. PubMed ID: 33052706
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
